Unlock instant, AI-driven research and patent intelligence for your innovation.

Melt-processed polymeric cellular dosage form

A cell-like, dosage-form technology, applied in the direction of pill delivery, bulk delivery, organic active ingredients, etc., can solve the problems of low drug release rate, only suitable for long-term release or sustained release, not suitable for immediate drug release, etc.

Inactive Publication Date: 2016-12-21
A H 布莱斯
View PDF5 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, multiple studies have shown that castable dosage forms, especially if they consist of bioinert and chemically and physically stable polymeric excipients, are only suitable for long-term or sustained release
They are not suitable for immediate drug release because the casting matrix resists leakage of the dissolution medium, resulting in a low rate of drug release

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Melt-processed polymeric cellular dosage form
  • Melt-processed polymeric cellular dosage form
  • Melt-processed polymeric cellular dosage form

Examples

Experimental program
Comparison scheme
Effect test

example 1

[0175] Example 1: Preparation of Cellular Dosage Forms

[0176] This example demonstrates exemplary fabrication of cellular dosage forms. Acetaminophen and polyethylene glycol 8000 were chosen as active ingredients and excipients for this example.

[0177] Preparation of cellular dosage forms:

[0178] The acetaminophen powder was first screened using a stainless steel mesh (size No. 270) with a nominal opening of 53 μm. The drug particles were then combined with solid polyethylene glycol 8000 (PEG 8000) flakes to obtain a formulation of 63% acetaminophen and 37% PEG 8000 by weight. Then, the mixture was heated to 90° C. and kneaded until a homogeneous paste was formed. Subsequently, aliquots of the paste were placed in stainless steel molds maintained at 25°C. The aliquot was compressed and cooled to obtain a casting pan with a diameter of 13 mm and a thickness of 2.5 mm. This disc was used as a reference for the unfoamed sample. For the preparation of cell-like dosag...

example 2

[0180] Example 2: Images and Characterization of Microstructures

[0181] This example demonstrates exemplary characterization of the microstructure in cellular dosage forms using scanning electron microscope images.

[0182] Scanning Electron Microscope (SEM):

[0183] A cross-section of the dosage form showing its microstructure for SEM imaging was obtained by first scoring the sample with a razor blade and then fracturing it along the score. A Zeiss Merlin high resolution SEM with GEMINI column was used to acquire images. Imaging is performed with a lensed secondary electron detector. An accelerating voltage of 5 kV and a probing current of 95 pA were applied.

[0184] Referring to Figure 1, this shows the morphology of the structure which can be customized by adjusting the process conditions. High T s and p s Increased void volume fraction and open cell fraction. τ r Only minimally affects the void volume fraction, but has a dramatic effect on the diameter of the...

example 3

[0196] Example 3A: Lysis of Cellular Dosage Forms

[0197] This example demonstrates an exemplary dissolution test of a cellular dosage form showing that the dosage form is suitable for immediate drug release.

[0198] Dissolution test:

[0199]The dosage form is first attached to the annular disc. Then, the sample was placed at the bottom of a dissolution vessel (in Sotax dissolution bath) filled with 900 ml of 0.05 M phosphate buffer solution (using sodium dihydrogen phosphate and dihydrogen phosphate) at pH 5.8 and temperature 37°C sodium). The solution was stirred with a paddle rotating at 50 rpm. The concentration of dissolved drug was measured by UV absorbance at 244 nm using a fiber optic probe (Pion) with a path length of 2 mm.

[0200] Dissolving time t 0.8 OK for:

[0201] The time to dissolve 80% of the drug content was determined from a curve showing the amount of drug dissolved versus time.

[0202] Snapshots of dissolved closed-cell and open-cell dosage fo...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
sizeaaaaaaaaaa
thicknessaaaaaaaaaa
shear viscosityaaaaaaaaaa
Login to View More

Abstract

Presented herein are polymeric cellular dosage forms exhibiting improved immediate release properties, while maintaining high uniformity and satisfactory mechanical properties (e.g., to permit necessary handling). An exfoliating polymeric cellular dosage form is described herein that can be cost-effectively manufactured via batch or even non-batch (continuous or semi-continuous) melt processing. The solid dosage forms have a unique cellular microstructure featuring a number of open, interconnected cells. The cell walls contain the active ingredient(s) as well as an excipient that swells in the presence of a physiological fluid such as gastrointestinal fluid and / or saliva under physiological conditions.

Description

[0001] Cross References to Related Applications [0002] This application claims priority to and benefit of US Provisional Patent Application No. 61 / 986,262, filed April 30, 2014, which is hereby incorporated by reference in its entirety. technical field [0003] The present invention generally relates to microstructures, compositions and methods for immediate drug release. More specifically, in certain embodiments, the invention relates to cellular dosage forms. Background technique [0004] A pharmaceutical dosage form is a preparation of a biologically active drug substance and a pharmaceutical carrier or excipient. They can be solid, semi-solid (eg, ointment), liquid, or gas ranging in size from a few nanometers to a few millimeters. For decades, the most common dosage forms have been solids, especially immediate-release oral tablets and capsules. Generally, they consist of a granular material structure compounded by mixing and compacting drug and excipient particles...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K47/32A61K47/36
CPCA61K9/2095A61K31/167A61K31/616A61K9/1641
Inventor A·H·布莱斯N·萨卡
Owner A H 布莱斯